Balanced news tone
News Sentiment
VRTX sentiment intelligence
Vertex Pharmaceuticals Incorporated news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Price is moving more forcefully than the current news tone suggests.
85/100 classification confidence.
directly relevant articles
high-authority source matches
-7.8% over one week, +11.1% over four weeks, trend active, and near fair-value range.
Vertex Pharmaceuticals Incorporated (VRTX) Is a Trending Stock: Facts to Know Before Betting on It
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Vertex Pharmaceuticals Incorporated (VRTX) Is a Trending Stock: Facts to Know Before Betting on It
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Jul 2026 13:00
- Source
- Market source
Vertex Pharmaceuticals Stock 6-Day Losing Spree: Stock Falls 10%
- Tone
- Negative 22/100
- Event
- Market update
- Published
- 15 Jul 2026 14:27
- Source
- Trefis
Vertex Pharmaceuticals Stock Slides 10% Over 6 Straight Down Days
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Jul 2026 13:32
- Source
- Trefis
Is Vertex Pharmaceuticals (VRTX) A Bargain On Its Expanded CASGEVY Approval?
- Tone
- Neutral 50/100
- Event
- Regulatory and legal
- Published
- 14 Jul 2026 00:56
- Source
- simplywall.st
Vertex Pharmaceuticals (VRTX) Declines More Than Market: Some Information for Investors
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 13 Jul 2026 22:00
- Source
- Market source
What to Expect From Vertex Pharmaceuticals' Next Quarterly Earnings Report
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 13 Jul 2026 13:57
- Source
- Market source
Vertex Pharmaceuticals shares drop over 4% after Crinetics Pharmaceuticals $10B all-cash acquisition news
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 08 Jul 2026 19:25
- Source
- Traders Union
Vertex (VRTX) Stock May Be 36% Undervalued Following Its $10b Deal
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 08 Jul 2026 07:00
- Source
- Market source
Vertex Pharmaceuticals stock trades up to $529.75 as VertexPharma announces Crinetics acquisition
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 07 Jul 2026 00:05
- Source
- Traders Union
Investors Heavily Search Vertex Pharmaceuticals Incorporated (VRTX): Here is What You Need to Know
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 Jul 2026 07:00
- Source
- Market source
Therapeutics Stocks Q1 Recap: Benchmarking Vertex Pharmaceuticals (NASDAQ:VRTX)
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 30 Jun 2026 07:00
- Source
- Market source
Why the Market Dipped But Vertex Pharmaceuticals (VRTX) Gained Today
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 24 Jun 2026 07:00
- Source
- Market source
Positive Pediatric CASGEVY Data Might Change The Case For Investing In Vertex Pharmaceuticals (VRTX)
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 23 Jun 2026 07:00
- Source
- Market source
Vertex Pharmaceuticals (VRTX) Stock After Strong Multi‑Year Run Is The Price Still Reasonable
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 23 Jun 2026 07:00
- Source
- Market source
Rockefeller Capital stake increase propels Vertex Pharmaceuticals stock higher by 3.42%
- Tone
- Positive 66/100
- Event
- Deals and strategy
- Published
- 22 Jun 2026 07:00
- Source
- Traders Union
Why is Vertex Pharmaceuticals stock up today?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 22 Jun 2026 07:00
- Source
- Traders Union
Sustained momentum drives Vertex Pharmaceuticals stock higher despite signs of overbought conditions
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 04 Jun 2026 07:00
- Source
- Traders Union
Vertex Pharmaceuticals Insider Sold Shares Worth $888,300, According to a Recent SEC Filing
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Jun 2026 07:00
- Source
- marketscreener.com
Why is Vertex Pharmaceuticals stock down today?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Jun 2026 07:00
- Source
- Traders Union
Vertex Pharmaceuticals shares dip amid rising selling pressure
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 Jun 2026 07:00
- Source
- Traders Union
Buying pressure lifts Vertex Pharmaceuticals stock higher in today's trading
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 28 May 2026 07:00
- Source
- Traders Union
Vertex Pharmaceuticals Stock Analysis: 1991 IPO Growth and 2026 Outlook - News and Statistics
- Tone
- Positive 66/100
- Event
- Guidance
- Published
- 07 May 2026 07:00
- Source
- IndexBox
Germany backs access to Vertex's one-time gene therapy for blood disorders
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 06 May 2026 11:04
- Source
- Stock Titan
Vertex Pharmaceuticals Q1 2026 Earnings Preview: Revenue Growth of 6.5% Expected
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 04 May 2026 07:00
- Source
- IndexBox
(VRTX) Vertex Pharmaceuticals Expects 2026 Revenue Range $12.95B-$13.1B, vs. FactSet Est of $13.05B
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 04 May 2026 07:00
- Source
- marketscreener.com
A Look At Vertex Pharmaceuticals (VRTX) Valuation After Recent Share Price Weakness
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 28 Apr 2026 07:00
- Source
- Market source
Vertex Pharmaceuticals (VRTX) Stock Sinks As Market Gains: Here's Why
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 24 Apr 2026 07:00
- Source
- Market source
Vertex Pharmaceuticals (VRTX) Stock Slides as Market Rises: Facts to Know Before You Trade
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Apr 2026 07:00
- Source
- Market source
Vertex Pharmaceuticals (VRTX) Stock Drops Despite Market Gains: Important Facts to Note
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 02 Apr 2026 07:00
- Source
- Market source
Vertex Pharmaceuticals (VRTX) Stock Rises 5% on Kidney Drug Trial Win
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Mar 2026 07:00
- Source
- CoinCentral